Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amantadine for early COVID-19 to prevent clinical worsening
2021-001144-98Phase 3Terminated
- Sponsor
- Lublin Medical University Hospital
- Start
- Apr 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of amantadine in coronavirus disease 2019 (COVID-19), sponsored by Lublin Medical University Hospital. Primary endpoint: Clinical deterioration occurs. Started Apr 2021; status: terminated.
02
Drugs
amantadine
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on 2021-001144-98.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-001144-98.